Literature DB >> 9039091

Induction of growth hormone receptor and insulin-like growth factor-I mRNA in aorta and caval vein during hemodynamic challenge.

A Wickman1, P Friberg, M A Adams, G L Matejka, C Brantsing, G Guron, J Isgaard.   

Abstract

Induction of two-kidney, one clip hypertension (renal hypertension) is characterized by a slow increase in left ventricular tension and aortic wall stress, as opposed to aortocaval fistula or shunt volume overload, which induces a marked and rapid onset of wall stress in the caval vein and right ventricle. In the present study, we applied hemodynamic challenge to study the growth response involving gene expression of insulin-like growth factor-I (IGF-I) and growth hormone receptor (GH-R) mRNA in aorta and caval vein. Volume overload and pressure overload were induced in Wistar rats by means of shunt and renal hypertension, respectively. Systolic pressure was measured before excision of the great vessels, which was performed between 2 and 12 days postoperatively. Aortic and caval vein IGF-I and GH-R mRNA expressions were measured by means of a solution hybridization assay, and the caval vein was analyzed for IGF-I protein by immunohistochemistry. In the volume-distended but not pressurized caval vein in shunt rats, verified by telemetry recordings, there was an eightfold increase in IGF-I and 3.5-fold increase in GH-R mRNA at day 4 versus control. The IGF-I protein appeared to be localized in smooth muscle cells. In the aorta of the renal hypertension group, changes were of a slower onset. At day 7, there was a fourfold increase in IGF-I and five-fold increase of GH-R mRNA expressions versus sham-operated rats. Both the shunt caval vein and renal hypertension aorta showed evidence of a structural adaptation of the growth response. The present study suggests that acute elevation in vascular wall stress is an important triggering factor for overexpression of IGF-I and GH-R mRNA in great vessels. The growth hormone/insulin-like growth factor axis may be an important link in mediating structurally adaptive growth responses in the blood vessel wall.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039091     DOI: 10.1161/01.hyp.29.1.123

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

2.  Angiotensin converting enzyme I/D, angiotensinogen M235T and AT1-R A/C1166 gene polymorphisms in patients with acromegaly.

Authors:  Sebahat Turgut; Fulya Akın; Raziye Akcılar; Ceylan Ayada; Günfer Turgut
Journal:  Mol Biol Rep       Date:  2010-04-02       Impact factor: 2.316

3.  The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings.

Authors:  Carmen Gonzalez; Hector Rosas-Hernandez; Brenda Jurado-Manzano; Manuel Alejandro Ramirez-Lee; Samuel Salazar-Garcia; Pedro Pablo Martinez-Cuevas; Aída Jimena Velarde-Salcedo; Humberto Morales-Loredo; Ricardo Espinosa-Tanguma; Syed F Ali; Rafael Rubio
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

4.  Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy.

Authors:  S Jeson Sangaralingham; Brian J Pak; M Yat Tse; Ekaterini Angelis; Michael A Adams; C Smallegange; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

Review 5.  Pathogenesis and prevalence of hypertension in acromegaly.

Authors:  M Bondanelli; M R Ambrosio; E C degli Uberti
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

Review 6.  Hormone treatments in congestive heart failure.

Authors:  Lei Lei; Yuanjie Mao
Journal:  J Int Med Res       Date:  2018-02-22       Impact factor: 1.671

Review 7.  Insulin Receptors and Insulin Action in the Heart: The Effects of Left Ventricular Assist Devices.

Authors:  Konstantina Pantazi; Eleni Karlafti; Alexandra Bekiaridou; Matthaios Didagelos; Antonios Ziakas; Triantafyllos Didangelos
Journal:  Biomolecules       Date:  2022-04-14

Review 8.  GH and the cardiovascular system: an update on a topic at heart.

Authors:  Jörgen Isgaard; Michele Arcopinto; Kristjan Karason; Antonio Cittadini
Journal:  Endocrine       Date:  2014-06-28       Impact factor: 3.633

Review 9.  Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial.

Authors:  Diego Caicedo; Pablo Devesa; Clara V Alvarez; Jesús Devesa
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.